Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Oric Pharmaceuticals (ORIC) Other Operating Expenses (2020 - 2022)

Oric Pharmaceuticals filings provide 2 years of Other Operating Expenses readings, the most recent being $5.0 million for Q3 2022.

  • Quarterly Other Operating Expenses changed N/A to $5.0 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Jun 2023, changed N/A year-over-year, with the annual reading at $5.0 million for FY2022, N/A changed from the prior year.
  • Other Operating Expenses hit $5.0 million in Q3 2022 for Oric Pharmaceuticals, down from $11.9 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $13.0 million in Q3 2020 and bottomed at $5.0 million in Q3 2022.